These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7578742)

  • 21. Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent.
    McGee WT; Tereso GJ
    Crit Care Med; 2003 May; 31(5):1577-8. PubMed ID: 12771636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study.
    Zilberberg M; Yu HT; Chaudhari P; Emons MF; Khandelwal N; Shorr AF
    Crit Care; 2014 Oct; 18(5):590. PubMed ID: 25358521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oropharyngeal Candidiasis in Palliative Care Patients in Denmark.
    Astvad K; Johansen HK; Høiby N; Steptoe P; Ishøy T
    J Palliat Med; 2015 Nov; 18(11):940-4. PubMed ID: 26270132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
    Playford EG; Marriott D; Nguyen Q; Chen S; Ellis D; Slavin M; Sorrell TC
    Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV
    Shokri H; Sharifzadeh A
    J Mycol Med; 2017 Jun; 27(2):159-165. PubMed ID: 28159362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.
    Groll AH; Just-Nuebling G; Kurz M; Mueller C; Nowak-Goettl U; Schwabe D; Shah PM; Kornhuber B
    J Antimicrob Chemother; 1997 Dec; 40(6):855-62. PubMed ID: 9462438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
    Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
    Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluconazole prophylaxis against fungal colonization and infection in preterm infants.
    Kaufman D; Boyle R; Hazen KC; Patrie JT; Robinson M; Donowitz LG
    N Engl J Med; 2001 Dec; 345(23):1660-6. PubMed ID: 11759644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Isolation rate and susceptibilities of candida species from blood, vascular catheter, urine and stool].
    Tashiro M; Murakami H; Yoshizawa S; Tateda K; Yamaguchi K
    Kansenshogaku Zasshi; 2012 Mar; 86(2 Suppl 4):15-20. PubMed ID: 23115940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis.
    Arikan S; Akova M; Hayran M; Ozdemir O; Erman M; Gür D; Unal S
    Clin Infect Dis; 1998 Apr; 26(4):903-8. PubMed ID: 9564473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V; Barnes AJ
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Candida inconspicua, a fluconazole-resistant pathogen in patients infected with human immunodeficiency virus.
    Baily GG; Moore CB; Essayag SM; de Wit S; Burnie JP; Denning DW
    Clin Infect Dis; 1997 Jul; 25(1):161-3. PubMed ID: 9243058
    [No Abstract]   [Full Text] [Related]  

  • 33. [Level of evidence for therapeutic drug monitoring of fluconazole].
    Venisse N; Le Guellec C
    Therapie; 2011; 66(2):97-101. PubMed ID: 21635855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
    Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F
    Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
    Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
    Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose fluconazole therapy in patients with severe fungal infections.
    Voss A; de Pauw BE
    Eur J Clin Microbiol Infect Dis; 1999 Mar; 18(3):165-74. PubMed ID: 10357048
    [No Abstract]   [Full Text] [Related]  

  • 37. Vulvovaginal candidiasis in a Flemish patient population.
    De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ
    Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caspofungin in kidney transplant recipients with refractory invasive candidiasis.
    Veroux M; Corona D; Macarone M; Gagliano M; Giuffida G; Veroux P
    Nephrol Dial Transplant; 2007 May; 22(5):1487-9. PubMed ID: 17210588
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of fluconazole consumption on long-term trends in candidal ecology.
    Blot S; Janssens R; Claeys G; Hoste E; Buyle F; De Waele JJ; Peleman R; Vogelaers D; Vandewoude K
    J Antimicrob Chemother; 2006 Aug; 58(2):474-7. PubMed ID: 16757503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluconazole dose recommendation in urinary tract infection.
    Boedeker KS; Kilzer WJ
    Ann Pharmacother; 2001 Mar; 35(3):369-72. PubMed ID: 11261537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.